Table 7.
Demographic and biochemical characteristics of the total end-stage kidney disease (ESKD) cohort and according to the percentage of sclerostin-positive lacunae (i.e., below versus equal or above the median of 43%).
| ESKD Patients, All | Sclerostin-Positive Lacunae < 43% | Sclerostin-Positive Lacunae ≥ 43% | p-Value | ||||
|---|---|---|---|---|---|---|---|
| Clinical and biochemical characteristics | |||||||
| Age | 57 | (21) | 58 | (25) | 55 | ±10.34 | 0.8377 |
| BMI | 26 | ±5 | 25 | ±5 | 26 | ±5 | 0.2926 |
| Renal residual function (mL/24 h) | 500 | (963) | 707 | ±672 | 741 | (1000) | 0.9508 |
| Dialysis vintage (months) | 30.4 | ±18.1 | 29.6 | ±17.2 | 31.4 | ±19.3 | 0.8424 |
| Serum Calcium (mg/dL) | 9.4 | (1.0) | 9.4 | (0.9) | 9.4 | ±0.7 | 0.3625 |
| Serum Phosphate (mg/dL) | 4.6 | ±1.4 | 4.6 | ±1.5 | 4.6 | ±1.4 | 0.9626 |
| Serum CRP (mg/L) | 3.3 | (5.0) | 3.6 | (5.1) | 3.0 | (6.7) | 0.4871 |
| Serum IL-6 (pg/mL) | 1.4 | (2.1) | 1.6 | (2.6) | 1.2 | (2.1) | 0.0819 |